Treatment Improvement Protocol (TIP) 63: Medications for Opioid Use Disorder

Treatment Improvement Protocol (TIP) 63: Medications for Opioid Use Disorder
Title:
Treatment Improvement Protocol (TIP) 63: Medications for Opioid Use Disorder
Format:
EPUB
USA Price: 
Stock:
Digital Download
GPO Stock Number:
017-300-00047-4
ISBN:
9780160943751
Description

The Substance Abuse and Mental Health Services Administration (SAMHSA) is the U.S. Department of Health and Human Services agency that leads public health efforts to advance the behavioral health of the nation. SAMHSA’s mission is to reduce the impact of substance abuse and mental illness on America’s communities. The Treatment Improvement Protocol (TIP) series fulflls SAMHSA’s mission by providing sciencebased best-practice guidance to the behavioral health feld. TIPs refect careful consideration of all relevant clinical and health service research, demonstrated experience, and implementation requirements. Select nonfederal clinical researchers, service providers, program administrators, and patient advocates comprising each TIP’s consensus panel discuss these factors, offering input on the TIP’s specifc topic in their areas of expertise to reach consensus on best practices. Field reviewers then assess draft content. 

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat opioid use disorder (OUD)—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.

From our blog: https://govbooktalk.gpo.gov/2018/05/07/new-federal-government-publication-offers-help-to-combat-opioid-crisis/

Agency website: https://www.samhsa.gov/

 

Table of Contents

Part 1: Introduction to Medications for Opioid Use Disorder Treatment For healthcare and addiction professionals, policymakers, patients, and families

Part 2: Addressing Opioid Use Disorder in General Medical Settings For healthcare professionals

Part 3: Pharmacotherapy for Opioid Use Disorder For healthcare professionals

Part 4: Partnering Addiction Treatment Counselors With Clients and Healthcare Professionals For healthcare and addiction professionals

Part 5: Resources Related to Medications for Opioid Use Disorder For healthcare and addiction professionals, policymakers, patients, and families 

EXECUTIVE SUMMARY

Foreword ES-iii

Introduction ES-1

Overall Key Messages  ES-1

Content Overview  ES-3

Notes  ES-6

TIP Development Participants  ES-8

Publication Information  ES-12

PART 1:

AN INTRODUCTION TO MEDICATIONS FOR THE TREATMENT OF OPIOID USE DISORDER

The Approach to OUD Care  1-1

Overview of Medications for OUD 1-3

Duration of Treatment With OUD Medication 1-8

Treatment Settings  1-9

Challenges to Expanding Access to OUD Medication 1-9

Resources 1-10

Notes 1-11

PART 2: ADDRESSING OPIOID USE DISORDER IN GENERAL MEDICAL SETTINGS

Scope of the Problem  2-1  

Screening  2-1

Assessment  2-8

Treatment Planning or Referral  2-17

Resources  2-28

Appendix  2-32

Notes  2-39

iii MEDICATIONS FOR OPIOID USE DISORDER TIP 63

PART 3: PHARMACOTHERAPY FOR OPIOID USE DISORDER

Pharmacotherapy for Opioid Use Disorder  3-1

Chapter 3A: Overview of Pharmacotherapy for Opioid Use Disorder 3-5

Chapter 3B: Methadone 3-15 Chapter 3C:

Naltrexone  3-35

Chapter 3D:

Buprenorphine 3-49

Chapter 3E: Medical Management Strategies for Patients Taking OUD Medications in Ofce-Based Settings 3-79

Chapter 3F: Medical Management of Patients Taking OUD Medications in Hospital Settings  3-99

PART 4: PARTNERING ADDICTION TREATMENT COUNSELORS WITH CLIENTS AND HEALTHCARE PROFESSIONALS

Overview and Context  4-1

Quick Guide to Medications  4-12

Counselor–Prescriber Communications  4-18

Creation of a Supportive Counseling Experience  4-20

Other Common Counseling Concerns  4-34

Notes  4-37

PART 5: RESOURCES RELATED TO MEDICATIONS FOR OPIOID USE DISORDER

General Resources  5-1

Resources for Counselors and Peer Providers  5-10

Resources for Clients and Families  5-11

Provider Tools and Sample Forms 5-17

Glossary of TIP Terminology  5-57

Notes  5-60 

Audience

Healthcare and Addiction Professionals, Policymakers, Patients, and Families

Back to Top